Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
126M
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
362K
-
Shares change
-
+195K
-
Total reported value, excl. options
-
$212K
-
Value change
-
+$113K
-
Number of buys
-
10
-
Number of sells
-
-4
-
Price
-
$0.59
Significant Holders of NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value (NBY) as of Q1 2025
17 filings reported holding NBY - NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value as of Q1 2025.
NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value (NBY) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 362K shares
of 126M outstanding shares and own 0.29% of the company stock.
Largest 10 shareholders include SABBY MANAGEMENT, LLC (218K shares), C2C Wealth Management, LLC (55K shares), GEODE CAPITAL MANAGEMENT, LLC (35K shares), XTX Topco Ltd (19.8K shares), TWO SIGMA SECURITIES, LLC (17.5K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (10.6K shares), Tower Research Capital LLC (TRC) (5.46K shares), UBS Group AG (749 shares), SBI Securities Co., Ltd. (53 shares), and BANK OF AMERICA CORP /DE/ (43 shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.